Abstract
Deletion of all or part of chromosome 9q is the most common genetic alteration in all stages and grades of bladder cancer. DBCCR1 (deleted in bladder cancer chromosome region candidate 1) maps to the chromosome region 9q32-33, a candidate tumour suppressor locus for bladder cancer. Although no mutations of DBCCR1 have been detected in bladder tumours, expression of DBCCR1 is silenced by promoter hypermethylation in 50% of bladder cancer cell lines analysed. Here we sought to provide functional evidence to authenticate DBCCR1 as a tumour suppressor using gene-transfer methods. Exogenous expression of DBCCR1 protein or an HA epitope-tagged fusion protein, HA-DBCCR1 in NIH3T3 cells and human bladder tumour cell lines resulted in suppression of proliferation. Cell cycle analyses in NIH3T3 cells revealed that DBCCR1-mediated growth inhibition was due to an increase in the number of cells in the G1 phase of the cell cycle. The levels of apoptosis were not altered. These results demonstrate a role for DBCCR1 in cell cycle control, thereby supporting the hypothesis that this is the tumour suppressor gene targeted by 9q32-33 deletion in bladder cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cairns P, Shaw ME, Knowles MA . 1993 Oncogene 8: 1083–1085
Dalbagni G, Presti J, Reuter V, Fair WR, Cordon-Cardo C . 1993 Lancet 342: 469–471
Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP . 1998 Nat. Genet. 19: 348–355
Ewen ME, Sluss HK, Whitehouse LL, Livingston DM . 1993 Cell 74: 1009–1020
Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ . 1998 Nature 396: 177–180
Habuchi T, Devlin J, Elder PA, Knowles MA . 1995 Oncogene 11: 1671–1674
Habuchi T, Luscombe M, Elder PA, Knowles MA . 1998 Genomics 48: 277–288
Habuchi T, Takahashi T, Kakinuma H, Wang L, Tsuchiya N, Satoh S, Akao T, Sato K, Ogawa O, Knowles MA, Kato T . 2001 Oncogene in press
Habuchi T, Yoshida O, Knowles MA . 1997 Hum. Mol. Genet. 6: 913–919
Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R . 1999 Am. J. Pathol. 154: 721–727
Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, Mayer RJ, Arii S, Fujita J . 2000 Nat. Med. 6: 96–99
Kinzler KW, Vogelstein B . 1996 Cell 87: 159–170
Knudson Jr. AG . 1971 Proc. Natl. Acad. Sci. USA 68: 820–823
Niman HL, Houghten RA, Walker LE, Reisfeld RA, Wilson IA, Hogle JM, Lerner RA . 1983 Proc. Natl. Acad. Sci. USA 80: 4949–4953
Nishiyama H, Hornigold N, Davies AM, Knowles MA . 1999a Genomics 59: 335–338
Nishiyama H, Itoh K, Kaneko Y, Kishishita M, Yoshida O, Fujita J . 1997 J. Cell Biol. 137: 899–908
Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA . 1999b Genes Chromo. Cancer 26: 171–175
Office for National Statistics . 1996 ONS monitor MB1 96/1
Olumi AF, Tsai YC, Nichols PW, Skinner DG, Cain DR, Bender LI, Jones PA . 1990 Cancer Res. 50: 7081–7083
Parker S, Tong T, Balder S, Wingo P . 1997 CA Cancer J. Clin. 47: 5–27
Pestov DG, Polonskaia M, Lau LF . 1999 Biotechniques 26: 102–106
Ravitz MJ, Wenner CE . 1997 Adv. Cancer Res. 71: 165–207
Roussel MF . 1999 Oncogene 18: 5311–5317
Salem C, Liang G, Tsai YC, Coulter J, Knowles MA, Feng AC, Groshen S, Nichols PW, Jones PA . 2000 Cancer Res. 60: 2473–2476
Simoneau M, Aboulkassim TO, LaRue H, Rousseau F, Fradet Y . 1999 Oncogene 18: 157–163
Sionov RV, Haupt Y . 1999 Oncogene 18: 6145–6157
Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA . 1995 Hum. Mol. Gene. 4: 1569–1577
Wu SQ, Storer BE, Bookland EA, Klingelhutz AJ, Gilchrist KW, Meisner LF, Oyasu R, Reznikoff CA . 1991 Cancer Res. 51: 3323–3326
Acknowledgements
We are grateful to Dr D Pestov, Dr K Maruyama, and Dr J Fujita for providing expression constructs. We also thank Dr K Sibley and Dr NJ Hornigold for helpful suggestions in the preparation of the manuscript. This work was supported by the Imperial Cancer Research Fund.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishiyama, H., Gill, J., Pitt, E. et al. Negative regulation of G1/S transition by the candidate bladder tumour suppressor gene DBCCR1. Oncogene 20, 2956–2964 (2001). https://doi.org/10.1038/sj.onc.1204432
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204432
Keywords
This article is cited by
-
Brinp1 −/− mice exhibit autism-like behaviour, altered memory, hyperactivity and increased parvalbumin-positive cortical interneuron density
Molecular Autism (2016)
-
Cortical neurons gradually attain a post-mitotic state
Cell Research (2016)
-
Identification of 5 novel genes methylated in breast and other epithelial cancers
Molecular Cancer (2010)
-
DBC1 re-expression alters the expression of multiple components of the plasminogen pathway
Oncogene (2006)
-
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer
Nature Clinical Practice Urology (2005)